Leadership & Pay ·
TELA Bio, Inc. announced the departure of Antony Koblish as Chief Executive Officer and Director, effective August 3…
TELATELA Bio, Inc.
TELA Bio, Inc. announced the departure of Antony Koblish as Chief Executive Officer and Director, effective August 3, 2026. The Board appointed Heather Getz as the new CEO and a Class II director on the same date. Getz’s employment agreement includes an annual base salary of $650,000 and a target bonus of 100% of her salary. She received initial equity inducement grants consisting of 1,365,000 standard options, 1,005,000 premium-priced options, and 500,000 restricted stock units. The filing notes that Koblish’s resignation was not due to disagreements regarding operations or policies. TELA Bio operates in the medical device industry, specializing in wound care solutions.